Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational... see more

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > Worst management
View:
Post by goldtech on Jun 28, 2022 12:04pm

Worst management

These coercive Directors are the worst in the history of this company. Gene still pays Elliott and keeps him stealing money and shares. Now they pat themselves on the back by screwing the shareholders and will soon announce another financing to steal even more of our money When will we finally change this ridiculous board with capable people who actually do something for shareholders and not themselves.
Comment by M101 on Jun 28, 2022 4:40pm
True, but it's a microcosm of the US so two takeaways: 1) other clowns we could pay would be no less self dealing, and 2) our window of opportunity is closing.
Comment by bball67 on Jun 28, 2022 4:58pm
Disagree, not clowns. How about a little bit of respect. Window is open, nobody has an answer for ALZ or ALS. Gene and Elliot are not stealing shares, as insiders they just bought a substantial number of shares out of their own pockets which I commend them for. 
Comment by M101 on Jun 28, 2022 5:48pm
Elliot was a clown, but I don't know if Gene is still paying him.  When it mattered, Gene took the money up front knowing that it increased our risk of bankruptcy, so I'm going to assume he only appointed others of the same calibre, and it's still mostly his board. As for the window, I guess that was ambiguous as your interpretation is not at all what I meant. I was opining again ...more  
Comment by BottomBroker on Jun 28, 2022 7:45pm
Alternatively, that tipping point was avoided when the Boston group stepped in with their injection of cash. 
Comment by M101 on Jun 28, 2022 8:30pm
I'll concede it did get top billing in the joint announcement.
Comment by BottomBroker on Jun 29, 2022 9:34am
M101, interested in your opinion re: Gene and Elliot and their current roles/influence. My feeling is that they are now only figureheads, and the Boston group is steering the ship. 
Comment by M101 on Jun 29, 2022 10:29am
Elliot seems to have disappeared from all correspondence so he's not a figurehead. Gene now reports to an investor group so that has probably crimped his style, but he's not Martin Tolar, he didn't have much style to crimp. So I doubt that his job has changed much outside of a loss in autonomy over board picks and how and when to raise cash.